Advertisement

Setting-Specific Treatment Issues

  • Azziza Oluwakemi Bankole
  • Mamta Sapra
Chapter

Abstract

Aging is now an integral part of society, and in short, we expect to grow old. The average lifespan has increased as a result of declining childhood and elderly mortality rates. Associated with our increased lifespan is the rising prevalence of chronic illnesses such as cardiovascular diseases, neurocognitive disorders, diabetes, cancer, and mobility impairment. Health-care providers must take into consideration the impact of the various factors that have an impact on older adults, how they experience illnesses, and their ability to communicate their experience to us. The setting in which older adults are seen and treated necessarily will have an impact on their experience and expectations. Understanding these dynamics is a critical part in the caregiving process. In this chapter, we provide a background on the different settings that older adults receive treatment and explore their role in presentation, diagnosis, and treatment of various psychiatric disorders.

Keywords

Long-term care Skilled nursing facilities Nursing home Adult daycare centers 

References

  1. 1.
    Kemper P, Komisar HL, Alecxih L. Long-term care over an uncertain future: what can current retirees expect? Inquiry. 2005–2006;42(4):335–50.CrossRefPubMedGoogle Scholar
  2. 2.
    Vincent GK, Velkoff VA. The next four decades: the older population in the United States: 2010 to 2050. Current population reports. Washington, DC: US Census Bureau; 2010. p. 25–1138.Google Scholar
  3. 3.
    Jones AL, Dwyer LL, Bercovitz AR, Strahan GW. The National Nursing Home Survey: 2004 overview. Vital Health Stat 13. 2009;167:1–155.Google Scholar
  4. 4.
    Seitz D, Purandare N, Conn D. Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review. Int Psychogeriatr. 2010;22(7):1025–39.CrossRefPubMedGoogle Scholar
  5. 5.
    Harris-Kojetin L, Sengupta M, Park-Lee E, Valverde R, Caffrey C, Rome V, Lendon J. Long-term care providers and services users in the United States: data from the National Study of long-term care providers, 2013–2014. Vital Health Stat 3. 2016;38(x–xii):1–105.Google Scholar
  6. 6.
    Forster A, Lambley R, Hardy J, Young J, Smith J, Green J, Burns E. Rehabilitation for older people in long-term care. Cochrane Database Syst Rev. 2009;1:CD004294.Google Scholar
  7. 7.
    Carpenter GI, Hastie CL, Morris JN, Fries BE, Ankri J. Measuring change in activities of daily living in nursing home residents with moderate to severe cognitive impairment. BMC Geriatr. 2006;6:7.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Lorenz RA, Gooneratne N, Cole CS, Kleban MH, Kalra GK, Richards KC. Exercise and social activity improve everyday function in long-term care residents. Am J Geriatr Psychiatry. 2012;20(6):468–76.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Owsley C, Sloane M, McGwin G Jr, Ball K. Timed instrumental activities of daily living tasks: relationship to cognitive function and everyday performance assessments in older adults. Gerontology. 2002;48(4):254–65.CrossRefPubMedGoogle Scholar
  10. 10.
    Boyce RD, Hanlon JT, Karp JF, Kloke J, Saleh A, Handler SM. A review of the effectiveness of antidepressant medications for depressed nursing home residents. Am Med Dir Assoc. 2012;13(4):326–31.CrossRefGoogle Scholar
  11. 11.
    Koenig HG, Meador KG, Cohen HJ, Blazer DG. Depression in elderly hospitalized patients with medical illness. Arch Intern Med. 1988;148(9):1929–36.CrossRefPubMedGoogle Scholar
  12. 12.
    Mitchell AJ, Bird V, Rizzo M, Meader N. Which version of the geriatric depression scale is most useful in medical settings and nursing homes? Diagnostic validity meta-analysis. Am J Geriatr Psychiatry. 2010;18(12):1066–77.CrossRefPubMedGoogle Scholar
  13. 13.
    Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982–1983;17(1):37–49.CrossRefPubMedGoogle Scholar
  14. 14.
    Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey MB, Leirer VO. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1983;17:37–49.CrossRefGoogle Scholar
  15. 15.
    Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23(3):271–84.CrossRefPubMedGoogle Scholar
  16. 16.
    Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.PubMedCentralCrossRefPubMedGoogle Scholar
  17. 17.
    Teresi J, Abrams R, Holmes D, et al. Prevalence of depression and depression recognition in nursing homes. Soc Psychiatry Psychiatr Epidemiol. 2001;36:613–20.CrossRefPubMedGoogle Scholar
  18. 18.
    Watson LC, Zimmerman S, Cohen LW, Dominik R. Practical depression screening in residential care/assisted living: five methods compared with gold standard diagnoses. Am J Geriatr Psychiatry. 2009;17(7):556–64.PubMedCentralCrossRefPubMedGoogle Scholar
  19. 19.
    Jeon YH, Liu Z, Li Z, Low LF, Chenoweth L, O'Connor D, Beattie E, Davison TE, Brodaty H. Development and validation of a short version of the Cornell scale for depression in dementia for screening residents in nursing homes. Am J Geriatr Psychiatry. 2016;24(11):1007–16.CrossRefPubMedGoogle Scholar
  20. 20.
    Blank K, Gruman C, Robison JT. Case-finding for depression in elderly people: balancing ease of administration with validity in varied treatment settings. J Gerontol A Biol Sci Med Sci. 2004;59(4):378–84.CrossRefPubMedGoogle Scholar
  21. 21.
    Simning A, Simons KV. Treatment of depression in nursing home residents without significant cognitive impairment: a systematic review. Int Psychogeriatr. 2017;29(2):209–26.CrossRefPubMedGoogle Scholar
  22. 22.
    Wang JJ. The effects of reminiscence on depressive symptoms and mood status of older institutionalized adults in Taiwan. Int J Geriatr Psychiatry. 2005;20(1):57–62.CrossRefPubMedGoogle Scholar
  23. 23.
    Chiang KJ, Chu H, Chang HJ, Chung MH, Chen CH, Chiou HY, Chou KR. The effects of reminiscence therapy on psychological well-being, depression, and loneliness among the institutionalized aged. Int J Geriatr Psychiatry. 2010;25(4):380–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Burrows AB, Salzman C, Satlin A, Noble K, Pollock BG, Gersh T. A randomized, placebo-controlled trial of paroxetine in nursing home residents with non-major depression. Depress Anxiety. 2002;15(3):102–10.CrossRefPubMedGoogle Scholar
  25. 25.
    Oslin DW, Ten Have TR, Streim JE, Datto CJ, Weintraub D, DiFilippo S, Katz IR. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry. 2003;64(8):875–82.CrossRefPubMedGoogle Scholar
  26. 26.
    Streim JE, Oslin DW, Katz IR, Smith BD, DiFilippo S, Cooper TB, Ten Have T. Drug treatment of depression in frail elderly nursing home residents. Am J Geriatr Psychiatry. 2000;8(2):150–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Katz IR, Parmelee PA. Overview. In: Rubinstein RL, Lawton MP, editors. Depression in long term and residential care. New York: Springer; 1997. p. 1–25.Google Scholar
  28. 28.
    Creighton AS, Davison TE, Kissane DW. The prevalence of anxiety among older adults in nursing homes and other residential aged care facilities: a systematic review. Int J Geriatr Psychiatry. 2016;31(6):555–66.CrossRefPubMedGoogle Scholar
  29. 29.
    Creighton AS, Davison TE, Kissane DW. The correlates of anxiety among older adults in nursing home and other residential aged care facilities: a systematic review. Int J Geriatr Psychiatry. 2017;32(2):141–54.CrossRefPubMedGoogle Scholar
  30. 30.
    Mansbach WE, Mace RA, Clark KM. The Brief Anxiety and Depression Scale (BADS): a new instrument for detecting anxiety and depression in long-term care residents. Int Psychogeriatr. 2015;27(4):673–81.CrossRefPubMedGoogle Scholar
  31. 31.
    Gerolimatos LA, Gregg JJ, Edelstein BA. Assessment of anxiety in long-term care: examination of the Geriatric Anxiety Inventory (GAI) and its short form. Int Psychogeriatr. 2013;25(9):1533–42.CrossRefPubMedGoogle Scholar
  32. 32.
    Stanley MA, Beck JG, Novy DM, Averill PM, Swann AC, Diefenbach GJ, Hopko DR. Cognitive-behavioral treatment of late-life generalized anxiety disorder. J Consult Clin Psychol. 2003;71(2):309–19.CrossRefPubMedGoogle Scholar
  33. 33.
    Wetherell JL, Gatz M, Craske MG. Treatment of generalized anxiety disorder in older adults. J Consult Clin Psychol. 2003;71(1):31–40.CrossRefPubMedGoogle Scholar
  34. 34.
    Flint AJ. Generalised anxiety disorder in elderly patients: epidemiology, diagnosis and treatment options. Drugs Aging. 2005;22(2):101–14.CrossRefPubMedGoogle Scholar
  35. 35.
    Sung HC, Chang AM, Lee WL. A preferred music listening intervention to reduce anxiety in older adults with dementia in nursing homes. J Clin Nurs. 2010;19(7–8):1056–64.CrossRefPubMedGoogle Scholar
  36. 36.
    Stevenson DG, Decker SL, Dwyer LL, Huskamp HA, Grabowski DC, Metzger ED, Mitchell SL. Antipsychotic and benzodiazepine use among nursing home residents: findings from the 2004 National Nursing Home Survey. Am J Geriatr Psychiatry. 2010;18(12):1078–92.PubMedCentralCrossRefPubMedGoogle Scholar
  37. 37.
    American Psychiatric Association. Benzodiazepine dependence, toxicity and abuse. Washington, DC: American Psychiatric Association; 1990.Google Scholar
  38. 38.
    Chen L, Bell JS, Visvanathan R, Hilmer SN, Emery T, Robson L, Hughes JM, Tan EC. The association between benzodiazepine use and sleep quality in residential aged care facilities: a cross-sectional study. BMC Geriatr. 2016;16(1):196.PubMedCentralCrossRefPubMedGoogle Scholar
  39. 39.
    Schweizer E, Rickels K, Lucki I. Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use. N Engl J Med. 1986;314:719–20.CrossRefPubMedGoogle Scholar
  40. 40.
    DeMartinis N, Rynn M, Rickels K, et al. Prior benzodiazepine use and buspirone response in the treatment of generalized anxiety disorder. J Clin Psychiatry. 2000;61:91–4.CrossRefPubMedGoogle Scholar
  41. 41.
    Abdulla A, Adams N, Bone M, Elliott AM, Gaffin J, Jones D, Knaggs R, Martin D, Sampson L, Schofield P. British geriatric society. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1–57.CrossRefPubMedGoogle Scholar
  42. 42.
    Vaismoradi M, Skär L, Söderberg S, Bondas TE. Normalizing suffering: a meta-synthesis of experiences of and perspectives on pain and pain management in nursing homes. Int J Qual Stud Health Well-being. 2016;11(1):31203.CrossRefPubMedGoogle Scholar
  43. 43.
    Liu JY, Leung DY. Pain treatments for nursing home residents with advanced dementia and substantial impaired communication: a cross-sectional analysis at baseline of a cluster randomized controlled trial. Pain Med. 2016;18(9):1649–57. pii: pnw242Google Scholar
  44. 44.
    Bauer U, Pitzer S, Schreier MM, Osterbrink J, Alzner R, Iglseder B. Pain treatment for nursing home residents differs according to cognitive state—a cross-sectional study. BMC Geriatr. 2016;16:124.PubMedCentralCrossRefPubMedGoogle Scholar
  45. 45.
    Won A, Lapane K, Gambassi G, Bernabei R, Mor V, Lipsitz LA, Nygaard HA, Jarland M. Correlates and management of nonmalignant pain in the nursing home. SAGE study group. Systematic assessment of geriatric drug use via epidemiology. J Am Geriatr Soc. 1999;47(8):936–42.CrossRefPubMedGoogle Scholar
  46. 46.
    Nygaard HA, Jarland M. Are nursing home patients with dementia diagnosis at increased risk for inadequate pain treatment? Int J Geriatr Psychiatry. 2005;20(8):730–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Feldt KS. The checklist of nonverbal pain indicators (CNPI). Pain Manag Nurs. 2000;1(1):13–21.CrossRefPubMedGoogle Scholar
  48. 48.
    US Department of Health and Human Services. https://www.guideline.gov/summaries/summary/45524
  49. 49.
    Sansoni J, Anderson KH, Varona LM, et al. Caregivers of Alzheimer’s patients and factors influencing institutionalization of loved ones: some considerations on existing literature. Ann Ig. 2013;25(3):235–46.PubMedGoogle Scholar
  50. 50.
    Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the minimum data set for nursing home resident assessment and care screening (MDS). Gerontologist. 1995;35(2):172–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Frederiksen K, Tariot P, De Jonghe E. Minimum Data Set Plus (MDS+) scores compared with scores from five rating scales. J Am Geriatr Soc. 1996;44(3):305–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Snowden M, McCormick W, Russo J, Srebnik D, Comtois K, Bowen J, Teri L, Larson EB. Validity and responsiveness of the minimum data set. J Am Geriatr Soc. 1999;47(8):1000–4.CrossRefPubMedGoogle Scholar
  53. 53.
    Conn DK, Seitz DP. Advances in the treatment of psychiatric disorders in long-term care homes. Curr Opin Psychiatry. 2010;23(6):516–21.CrossRefPubMedGoogle Scholar
  54. 54.
    O'Connor DW, Ames D, Gardner B, King M. Psychosocial treatments of psychological symptoms in dementia: a systematic review of reports meeting quality standards. Int Psychogeriatr. 2009;21(2):241–51.CrossRefPubMedGoogle Scholar
  55. 55.
    Kong EH, Evans LK, Guevara JP. Nonpharmacological intervention for agitation in dementia: a systematic review and meta-analysis. Aging Ment Health. 2009;13(4):512–20.CrossRefPubMedGoogle Scholar
  56. 56.
    Vernooij-Dassen M, Vasse E, Zuidema S, Cohen-Mansfield J, Moyle W. Psychosocial interventions for dementia patients in long-term care. nt Psychogeriatr. 2010;22(7):1121–8.CrossRefGoogle Scholar
  57. 57.
    Sorbi S, Hort J, Erkinjuntti T, Fladby T, Gainotti G, Gurvit H, Nacmias B, Pasquier F, Popescu BO, Rektorova I, Religa D, Rusina R, Rossor M, Schmidt R, Stefanova E, Warren JD, Scheltens P, EFNS Scientist Panel on Dementia and Cognitive Neurology. EFNS-ENS guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol. 2012;19(9):1159–79.CrossRefPubMedGoogle Scholar
  58. 58.
    Conn DK, Ferguson I, Mandelman K, Ward C. Psychotropic drug utilization in long-term-care facilities for the elderly in Ontario, Canada. Int Psychogeriatr. 1999;11(3):223–33.CrossRefPubMedGoogle Scholar
  59. 59.
    Seitz DP, Gruneir A, Conn DK, Rochon PA. Cholinesterase inhibitor use in U.S. nursing homes: results from the national nursing home survey. J Am Geriatr Soc. 2009;57(12):2269–74.CrossRefPubMedGoogle Scholar
  60. 60.
    Hawes C, Mor V, Phillips CD, Fries BE, Morris JN, Steele-Friedlob E, Greene AM, Nennstiel M. The OBRA-87 nursing home regulations and implementation of the resident assessment instrument: effects on process quality. J Am Geriatr Soc. 1997;45(8):977–85.CrossRefPubMedGoogle Scholar
  61. 61.
    Ryan JM, Kidder SW, Daiello LA, Tariot PN. Psychopharmacologic interventions in nursing homes: what do we know and where should we go? Psychiatr Serv. 2002;53(11):1407–13.CrossRefPubMedGoogle Scholar
  62. 62.
    Gurwitz JH, Field TS, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Edmondson AC, Bates DW. Incidence and preventability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87–94.CrossRefPubMedGoogle Scholar
  63. 63.
    Fields NL, Anderson KA, Dabelko-Schoeny H. The effectiveness of adult day services for older adults: a review of the literature from 2000 to 2011. J Appl Gerontol. 2014;33(2):130–63.CrossRefPubMedGoogle Scholar
  64. 64.
    Gaugler JE, Jarrott SE, Zarit SH, Stephens MP, Townsend A, Greene R. Adult day service use and reductions in caregiving hours: effects on stress and psychological well-being for dementia caregivers. Int J Geriatr Psychiatry. 2003;18(1):55–62.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Psychiatry and Behavioral MedicineVirginia Tech Carilion School of MedicineRoanokeUSA
  2. 2.Salem Veteran Affairs Medical CenterSalemUSA

Personalised recommendations